Eduardo Dunayevich

US Patent:

20130245056, Sep 19, 2013

Filed:

Dec 2, 2011

Appl. No.:

13/991137

Inventors:

Shawn Flanagan - San Diego CA, US
Eduardo Dunayevich - Westlake Village CA, US

Assignee:

Orexigen Therapeutics, Inc. - La Jolla CA

International Classification:

A61K 31/485
A61K 31/137

US Classification:

514282

Abstract:

Disclosed are compositions, uses, methods and kits for increasing drug bioavailability in a naltrexone therapy.

US Patent:

20130252995, Sep 26, 2013

Filed:

Dec 2, 2011

Appl. No.:

13/991372

Inventors:

Eduardo Dunayevich - Westlake Village CA, US
Susan Mcelroy - Mason OH, US
Ron Landbloom - Jersey City NJ, US

Assignee:

OREXIGEN THERAPEUTICS, INC. - La Jolla CA

International Classification:

A61K 31/485
A61K 9/00
A61K 31/137

US Classification:

514282

Abstract:

Compositions, uses, kits and methods for reducing binge or compulsive eating are described herein. Methods may include administering an effective combination of a dosage of a bupropion or a pharmaceutically acceptable salt thereof, and a dosage of naltrexone or a pharmaceutically acceptable salt thereof. Methods may include identifying a patient who is overweight or obese and providing an effective combination of bupropion and naltrexone to the patient. Methods may include reducing a number of binge or compulsive eating events. Methods may include reducing severity of binge or compulsive eating events.

US Patent:

20110172260, Jul 14, 2011

Filed:

Jan 10, 2011

Appl. No.:

12/987909

Inventors:

Eduardo Dunayevich - San Diego CA, US
Gary Tollefson - Indianapolis IN, US
David Dewitt - Indianapolis IN, US

Assignee:

Orexigen Therapeutics, Inc. - La Jolla CA

International Classification:

A61K 31/485
A61P 3/04
A61P 25/24

US Classification:

514282

Abstract:

Disclosed are methods of providing weight loss therapy, particularly for patients suffering from major depression.

US Patent:

20220233520, Jul 28, 2022

Filed:

Apr 11, 2022

Appl. No.:

17/717691

Inventors:

- Brentwood TN, US
Eduardo Dunayevich - Westlake Village CA, US

Assignee:

Nalpropion Pharmaceuticals LLC - Brentwood TN

International Classification:

A61K 31/485
A61K 31/137

Abstract:

Disclosed are compositions, uses, methods and kits for increasing drug bioavailability in a naltrexone therapy.

US Patent:

20230020514, Jan 19, 2023

Filed:

Sep 2, 2022

Appl. No.:

17/902168

Inventors:

- Thousand Oaks CA, US
Eduardo DUNAYEVICH - San Diego CA, US
Robert A. LENZ - Westlake Village CA, US
Gabriel VARGAS - Berkeley CA, US

Assignee:

AMGEN INC. - Thousand Oaks CA

International Classification:

C07K 16/28

Abstract:

The present invention relates to methods of migraine prophylaxis using anti-CGRP receptor antibodies or binding fragments. In particular, methods for preventing or reducing the occurrence of migraine headache in a patient in need thereof comprising administering to the patient an anti-CGRP receptor or binding fragment according to specific dosage regimens are disclosed. Pharmaceutical compositions and administration devices comprising anti-CGRP receptor antibodies or binding fragments for use in the methods are also described.

US Patent:

20190358222, Nov 28, 2019

Filed:

Aug 7, 2019

Appl. No.:

16/534509

Inventors:

- Morristown NJ, US
Eduardo Dunayevich - Westlake Village CA, US

International Classification:

A61K 31/485
A61K 31/137

Abstract:

Disclosed are compositions, uses, methods and kits for increasing drug bioavailability in a naltrexone therapy.

US Patent:

20190290640, Sep 26, 2019

Filed:

Jun 14, 2019

Appl. No.:

16/441863

Inventors:

- Morristown NJ, US
Eduardo Dunayevich - Westlake Village CA, US

International Classification:

A61K 31/485
A61P 3/04
A61K 9/00
A61K 31/439
A61K 31/137

Abstract:

Disclosed are methods of providing weight loss therapy, particularly for patients suffering from major depression.

US Patent:

20190256607, Aug 22, 2019

Filed:

Feb 27, 2019

Appl. No.:

16/287533

Inventors:

- Thousand Oaks CA, US
Eduardo Dunayevich - San Diego CA, US
Robert A. Lenz - Westlake Village CA, US
Gabriel Vargas - Berkeley CA, US

Assignee:

AMGEN INC. - Thousand Oaks CA

International Classification:

C07K 16/28

Abstract:

The present invention relates to methods of migraine prophylaxis using anti-CGRP receptor antibodies or binding fragments. In particular, methods for preventing or reducing the occurrence of migraine headache in a patient in need thereof comprising administering to the patient an anti-CGRP receptor or binding fragment according to specific dosage regimens are disclosed. Pharmaceutical compositions and administration devices comprising anti-CGRP receptor antibodies or binding fragments for use in the methods are also described.